These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 9023267

  • 1. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
    Coughenour LL, Cordon JJ.
    J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
    [Abstract] [Full Text] [Related]

  • 2. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits.
    Coughenour LL, Barr BM.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375
    [Abstract] [Full Text] [Related]

  • 3. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
    Williams K.
    Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of N-methyl-D-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition.
    Whittemore ER, Ilyin VI, Woodward RM.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):326-38. PubMed ID: 9223571
    [Abstract] [Full Text] [Related]

  • 5. Interaction of L-glutamate and magnesium with phencyclidine recognition sites in rat brain: evidence for multiple affinity states of the phencyclidine/N-methyl-D-aspartate receptor complex.
    Loo PS, Braunwalder AF, Lehmann J, Williams M, Sills MA.
    Mol Pharmacol; 1987 Dec; 32(6):820-30. PubMed ID: 2892125
    [Abstract] [Full Text] [Related]

  • 6. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
    Ilyin VI, Whittemore ER, Guastella J, Weber E, Woodward RM.
    Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
    [Abstract] [Full Text] [Related]

  • 7. Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex.
    Carter CJ, Lloyd KG, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1990 May; 253(2):475-82. PubMed ID: 1971016
    [Abstract] [Full Text] [Related]

  • 8. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex.
    Berger ML, Rebernik P.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of N-methyl-D-aspartate receptors by haloperidol: developmental and pharmacological characterization in native and recombinant receptors.
    Lynch DR, Gallagher MJ.
    J Pharmacol Exp Ther; 1996 Oct; 279(1):154-61. PubMed ID: 8858988
    [Abstract] [Full Text] [Related]

  • 10. The psychotomimetic drug phencyclidine labels two high affinity binding sites in guinea pig brain: evidence for N-methyl-D-aspartate-coupled and dopamine reuptake carrier-associated phencyclidine binding sites.
    Rothman RB, Reid AA, Monn JA, Jacobson AE, Rice KC.
    Mol Pharmacol; 1989 Dec; 36(6):887-96. PubMed ID: 2557536
    [Abstract] [Full Text] [Related]

  • 11. Modulation of Mg(2+)-dependent [3H]TCP binding by L-glutamate, glycine, and guanine nucleotides in rat cerebral cortex.
    Hori T, Yamamoto T, Hatta K, Moroji T.
    Synapse; 1991 May; 8(1):13-21. PubMed ID: 1678554
    [Abstract] [Full Text] [Related]

  • 12. [3H]ifenprodil binding to NMDA receptors in porcine hippocampal brain membranes.
    Höfner G, Wanner KT.
    Eur J Pharmacol; 2000 Apr 14; 394(2-3):211-9. PubMed ID: 10771286
    [Abstract] [Full Text] [Related]

  • 13. Re-evaluation of phencyclidine low-affinity or "non-NMDA" binding sites.
    Hirbec H, Mausset AL, Kamenka JM, Privat A, Vignon J.
    J Neurosci Res; 2002 May 01; 68(3):305-14. PubMed ID: 12111860
    [Abstract] [Full Text] [Related]

  • 14. Antagonist properties of the stereoisomers of ifenprodil at NR1A/NR2A and NR1A/NR2B subtypes of the NMDA receptor expressed in Xenopus oocytes.
    Avenet P, Léonardon J, Besnard F, Graham D, Frost J, Depoortere H, Langer SZ, Scatton B.
    Eur J Pharmacol; 1996 Jan 25; 296(2):209-13. PubMed ID: 8838458
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL, Gundlach AL, Snyder SH.
    J Pharmacol Exp Ther; 1986 Aug 25; 238(2):739-48. PubMed ID: 3016248
    [Abstract] [Full Text] [Related]

  • 16. Competitive inhibition of magnesium-induced [3H]N-(1-[thienyl] cyclohexyl)piperidine binding by arcaine: evidence for a shared spermidine-magnesium binding site.
    Sacaan AI, Johnson KM.
    Mol Pharmacol; 1990 Nov 25; 38(5):705-10. PubMed ID: 1978243
    [Abstract] [Full Text] [Related]

  • 17. Development of a selective competitive receptor binding assay for the determination of the affinity to NR2B containing NMDA receptors.
    Schepmann D, Frehland B, Lehmkuhl K, Tewes B, Wünsch B.
    J Pharm Biomed Anal; 2010 Nov 02; 53(3):603-8. PubMed ID: 20462722
    [Abstract] [Full Text] [Related]

  • 18. An aspartate residue in the extracellular loop of the N-methyl-D-aspartate receptor controls sensitivity to spermine and protons.
    Kashiwagi K, Fukuchi J, Chao J, Igarashi K, Williams K.
    Mol Pharmacol; 1996 Jun 02; 49(6):1131-41. PubMed ID: 8649353
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
    Sharma TA, Reynolds IJ.
    J Pharmacol Exp Ther; 1999 May 02; 289(2):1041-7. PubMed ID: 10215685
    [Abstract] [Full Text] [Related]

  • 20. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
    Kew JN, Trube G, Kemp JA.
    Br J Pharmacol; 1998 Feb 02; 123(3):463-72. PubMed ID: 9504387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.